92 Participants Needed

Limpet Device for Ostomy Complications

AO
Overseen ByAndy Obst
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: HealthPartners Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to evaluate the safety and effectiveness of the Limpet, as compared to standard of care ostomy pouches, in reducing complications for ostomy and fistula patients. Secondary objectives include evaluating dressing leak rates and causes of complications (e.g., edema, tissue oxygen saturation, and poor stoma eversion). The main questions it aims to answer are: Primary Hypothesis 1: Peristomal Skin Complications will decrease Primary Hypothesis 2: Dressing Leak Rates will decrease Participants will: * Receive either the Limpet device or standard of care adhesive ostomy pouch dressing * Return every 7 days for study visits for 30 days to receive device replacement, wound imaging, blood tests, and quality of life surveys.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, if you are scheduling or planning concurrent chemotherapy or radiation treatment, you may not be eligible to participate.

What data supports the effectiveness of the Limpet Device for treating ostomy complications?

The research on the Esteem synergy device, which is similar to the Limpet Device, showed positive results in terms of effectiveness, comfort, and quality of life for ostomized patients. This suggests that the Limpet Device may also be effective in managing ostomy complications.12345

How is the Limpet Device treatment different from other treatments for ostomy complications?

The Limpet Device is unique because it is a compressible isolation system designed to manage and protect the area around an ostomy or fistula, reducing leakage and skin irritation, which are common issues with traditional pouching systems. This innovative approach aims to improve patient comfort and quality of life by providing a more secure and effective seal compared to standard care options.13567

Eligibility Criteria

This trial is for adults over 18 who are having ileostomy surgery or have an enterocutaneous fistula with significant output. Their stoma should be no larger than 1.5 inches, and the skin around it must be intact. Participants need to follow the study's procedures and understand English, Spanish, Hmong, or Somali.

Inclusion Criteria

I have a fistula on my skin with a discharge of more than 500cc in 24 hours.
I am over 18 years old.
I am scheduled for ileostomy surgery.
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

4 weeks
1 visit (in-person)

Baseline

Baseline appointment clinic visit and randomization into treatment groups

1 day
1 visit (in-person)

Treatment

Participants receive either the Limpet device or standard of care adhesive ostomy pouch dressing with weekly clinic visits for device replacement, wound imaging, blood tests, and quality of life surveys

4 weeks
4 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Control
  • Limpet
Trial Overview The Limpet device is being tested against standard ostomy pouches to see if it reduces complications after surgery. Patients will either get the new device or a regular dressing and will visit weekly for a month for check-ups including wound imaging and blood tests.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: LimpetExperimental Treatment1 Intervention
Participants in this arm will utilize the subject device as intended to be used.
Group II: ControlActive Control1 Intervention
Standard treatment with standard of care adhesive ostomy pouches.

Find a Clinic Near You

Who Is Running the Clinical Trial?

HealthPartners Institute

Lead Sponsor

Trials
196
Recruited
3,721,000+

Findings from Research

The new fistula and wound management system was well-received by nurses, with 21 out of 22 expressing willingness to use it for future patients, indicating strong potential for clinical adoption.
Patients reported high mobility while using the new pouches (95% of the time) and the system demonstrated significantly longer wear time compared to traditional options, enhancing overall comfort and effectiveness in managing abdominal fistulas.
Management of fistulae in the abdominal region.Hocevar, BJ., Erwin-Toth, P., Landis-Erdman, J., et al.[2016]
The adapted Ostomy Skin Tool for Brazilian culture demonstrated strong convergent validity, showing a positive correlation (r = 0.44) with pain intensity in patients with peristomal skin complications, indicating it effectively measures relevant clinical outcomes.
Interrater reliability was moderate to high (κ = 0.48-0.93) when nurses assessed peristomal skin conditions in a clinical setting, suggesting that the tool can be reliably used by different healthcare professionals.
Cultural Adaptation and Validation of the Ostomy Skin Tool to the Brazilian Portuguese.Nunes, MLG., Martins, L., Conceição de Gouveia Santos, VL.[2023]
The Esteem synergy device, evaluated in a 16-week study with 591 ostomized patients across Spain, received 'very good' ratings in effectiveness, safety, comfort, and quality of life impact, indicating strong performance in clinical practice.
Patients consistently rated the Esteem synergy system positively, suggesting it is a suitable option for both in-hospital and out-patient use for individuals with colostomies and ileostomies.
[A new system to treat ostomy in Spain].[2006]

References

Management of fistulae in the abdominal region. [2016]
Cultural Adaptation and Validation of the Ostomy Skin Tool to the Brazilian Portuguese. [2023]
[A new system to treat ostomy in Spain]. [2006]
Demographic and clinical factors related to ostomy complications and quality of life in veterans with an ostomy. [2016]
Ostomy care: foundation for teaching and practice. [2007]
New Compressible Barrier Devices for Enteric Fistula and Ostomy Effluent Isolation. [2020]
International Consensus Results: Development of Practice Guidelines for Assessment of Peristomal Body and Stoma Profiles, Patient Engagement, and Patient Follow-up. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security